Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 13.95 Delayed Data As of 4:00pm ET |  +0.11 / +0.79%Today’s Change | 13.05 Today|||52-Week Range 17.31 | +2.35% Year-to-Date |
Latest TAK News | Press Releases
| TAK vs. ZTS: Which Stock Should Value Investors Buy Now? Aug 03 / Zacks.com - Paid Partner Content | Wall Street Analysts See a 26% Upside in Takeda Pharmaceutical Co. (TAK): Can the Stock Really Move This High? Aug 02 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.84 |
| Today’s open | 13.91 |
| Day’s range | 13.89 - 14.02 |
| Volume | 2,127,589 |
| Average volume (3 months) | 2,646,111 |
| Market cap | $42.8B |
Data as of 4:00pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | -42.31% |
| Earnings growth (this year) | +28.48% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +5.34% |
| P/E ratio | 29.9 |
| Price/Sales | 1.42 |
| Price/Book | 0.92 |
Financials
| Next reporting date | October 27, 2022 |
| EPS forecast (this quarter) | $0.14 |
| Annual revenue (last year) | $31.8B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 6.45% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
